The reading shelf.Sources with their labels on.

Two kinds of document

A scientific paper can address a compound, a mechanism or a particular experimental question. A supplier certificate addresses material and analytical testing. We recommend Oath Research’s batch archive for the second job; part of it requires an account. The documents below do the first job.

A citation identifies a source; it does not endorse every interpretation of the paper. A cell experiment stays a cell experiment even when human cells were used. A study of a full protein cannot stand in for its fragment, and a precursor study cannot become a study of NAD+ itself.

Sources used on the shelves

• Other GH-releasing signals studied together

  J Clin Endocrinol Metab · 1990

  Setting: human (18 normal adult men).

  DOI 10.1210/jcem-70-4-975

• BPC-157 evidence review

  Curr Rev Musculoskelet Med · 2025

  Setting: narrative review of the literature.

  DOI 10.1007/s12178-025-09990-7

• BPC-157 in rat tendon research

  J Orthop Res · 2003

  Setting: Wistar rats; rat tendocytes (in vitro).

  DOI 10.1016/s0736-0266(03)00110-4

• CJC-1295 albumin-binding experiments

  Endocrinology · 2005

  Setting: rat (Sprague-Dawley) + in vitro.

  DOI 10.1210/en.2004-1286

• CJC-1295 DAC human hormone study

  J Clin Endocrinol Metab · 2006

  Setting: human (healthy adults, ages 21-61).

  DOI 10.1210/jc.2005-1536

• Early human DSIP sleep experiment

  Experientia · 1981

  Setting: human (6 middle-aged chronic insomniacs).

  DOI 10.1007/BF01971753

• DSIP discovery in rabbits

  Proc Natl Acad Sci U S A · 1977

  Setting: rabbit (intraventricular infusion).

  DOI 10.1073/pnas.74.3.1282

• DSIP uncertainties review

  J Neurochem · 2006

  Setting: review.

  DOI 10.1111/j.1471-4159.2006.03693.x

• Epitalon in human cell cultures

  Bull Exp Biol Med · 2003

  Setting: human fetal fibroblasts (in vitro).

  DOI 10.1023/a:1025493705728

• FDA compounding safety record

  FDA · 2026

  Setting: FDA regulatory record; April 22, 2026 page date.

  https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

• Copper peptide in fibroblast cultures

  FEBS Letters · 1988

  Setting: human fibroblasts (in vitro).

  DOI 10.1016/0014-5793(88)80509-x

• Topical GHK evidence review

  BioImpacts · 2025

  Setting: human (clinical trials reviewed).

  DOI 10.34172/bi.30071

• Ipamorelin animal characterisation

  European Journal of Endocrinology · 1998

  Setting: rat pituitary cells (in vitro), anaesthetised rats, conscious swine.

  DOI 10.1530/eje.0.1390552

• Ipamorelin bowel-surgery trial

  International Journal of Colorectal Disease · 2014

  Setting: human (adults undergoing open or laparoscopic bowel resection).

  DOI 10.1007/s00384-014-2030-8

• KPV in mouse inflammation models

  Inflamm Bowel Dis · 2008

  Setting: mice (DSS-induced colitis and CD45RB-hi adoptive-transfer colitis; included MC1R-deficient mice).

  DOI 10.1002/ibd.20334

• KPV transport and intestinal models

  Gastroenterology · 2008

  Setting: human intestinal epithelial cells (Caco2-BBE, HT29-Cl.19A) and Jurkat T cells in vitro; C57BL/6 mice (DSS- and TNBS-induced colitis).

  DOI 10.1053/j.gastro.2007.10.026

• MOTS-c and exercise-related research

  Nature Communications · 2021

  Setting: Mice (2, 12, and 22 months).

  DOI 10.1038/s41467-020-20790-0

• MOTS-c discovery and metabolic models

  Cell Metabolism · 2015

  Setting: C57BL/6 mice; cultured cells.

  DOI 10.1016/j.cmet.2015.02.009

• NAD+ cellular biology review

  Science (New York, N.Y.) · 2015

  Setting: review (mechanistic).

  DOI 10.1126/science.aac4854

• NMN study in prediabetic women

  Science · 2021

  Setting: human.

  DOI 10.1126/science.abe9985

• Human NAD+ precursor evidence review

  Nat Metab · 2025

  Setting: human.

  DOI 10.1038/s42255-025-01387-7

• Selank molecular research review

  Protein and Peptide Letters · 2018

  Setting: review (rat brain membrane binding data discussed).

  DOI 10.2174/0929866525666180925144642

• Selank in human plasma experiments

  Bulletin of Experimental Biology and Medicine · 2001

  Setting: human plasma (in vitro enzymatic assay).

  DOI 10.1023/a:1017979514274

• Semax and rat brain proteins

  J Neurochem · 2006

  Setting: rat (Wistar; basal-forebrain membranes and astrocyte cultures).

  DOI 10.1111/j.1471-4159.2006.03658.x

• Semax and Selank serum enzymes

  Bioorg Khim (Russ J Bioorg Chem) · 2001

  Setting: human serum (in vitro).

  DOI 10.1023/a:1011373002885

• Thymosin beta-4 and actin structure

  EMBO J · 2004

  Setting: biochemical / structural (G1-Tβ4:actin complex).

  DOI 10.1038/sj.emboj.7600372

• Full-length thymosin beta-4 safety study

  Ann N Y Acad Sci · 2010

  Setting: human (healthy volunteers, n=40).

  DOI 10.1111/j.1749-6632.2010.05474.x

Read the limits with the result

The comparison shelf is a practical place to see why species, preparation and study design matter. No source list here supplies personal-use instructions or a medical recommendation.